Cargando…

Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra(®), TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome

BACKGROUND: Ezatiostat hydrochloride liposomes for injection, a glutathione S-transferase P1-1 inhibitor, was evaluated in myelodysplastic syndrome (MDS). The objectives were to determine the safety, pharmacokinetics, and hematologic improvement (HI) rate. Phase 1-2a testing of ezatiostat for the tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raza, Azra, Galili, Naomi, Callander, Natalie, Ochoa, Leonel, Piro, Lawrence, Emanuel, Peter, Williams, Stephanie, Burris, Howard, Faderl, Stefan, Estrov, Zeev, Curtin, Peter, Larson, Richard A, Keck, James G, Jones, Marsha, Meng, Lisa, Brown, Gail L
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694211/ https://www.ncbi.nlm.nih.gov/pubmed/19439093 http://dx.doi.org/10.1186/1756-8722-2-20

Ejemplares similares

Oral Ezatiostat HCl (TLK199) and Myelodysplastic syndrome: A case report of sustained hematologic response following an abbreviated exposure
por: Quddus, Fahd, et al.
Publicado: (2010)

Oral ezatiostat HCl (Telintra(®), TLK199) and Idiopathic Chronic Neutropenia (ICN): a case report of complete response of a patient with G-CSF resistant ICN following treatment with ezatiostat, a glutathione S-transferase P1-1 (GSTP1-1) inhibitor
por: Lyons, Roger M, et al.
Publicado: (2011)

Prediction of response to therapy with ezatiostat in lower risk myelodysplastic syndrome
por: Galili, Naomi, et al.
Publicado: (2012)

Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS)
por: Raza, Azra, et al.
Publicado: (2012)

Severe neurodevelopmental disease caused by a homozygous TLK2 variant
por: Töpf, Ana, et al.
Publicado: (2019)

Synchronization of optical links using the GOL with the TLK2501 or StratixGX buffers
por: Aslanides, Elie, et al.
Publicado: (2004)

Generation of Phenothiazine with Potent Anti-TLK1 Activity for Prostate Cancer Therapy
por: Singh, Vibha, et al.
Publicado: (2020)

Exploiting TLK1 and Cisplatin Synergy for Synthetic Lethality in Androgen-Insensitive Prostate Cancer
por: Bhoir, Siddhant, et al.
Publicado: (2023)

The radioresistance kinase TLK1B protects the cells by promoting repair of double strand breaks
por: Sunavala-Dossabhoy, Gulshan, et al.
Publicado: (2005)

Morphological Features of Adult Rats of IS/Kyo and IS-Tlk/Kyo Strains with Lumbar and Caudal Vertebral Anomalies
por: Takano, Masao, et al.
Publicado: (2014)

The circadian E3 ligase complex SCF(FBXL3+CRY) targets TLK2
por: Correia, Stephanie Papp, et al.
Publicado: (2019)

Comprehensive analysis of transcriptome characteristics and identification of TLK2 as a potential biomarker in dermatofibrosarcoma protuberans
por: Zhang, Xiao, et al.
Publicado: (2022)

The TLK1–MK5 Axis Regulates Motility, Invasion, and Metastasis of Prostate Cancer Cells
por: Khalil, Md Imtiaz, et al.
Publicado: (2022)

TLK1-mediated RAD54 phosphorylation spatio-temporally regulates Homologous Recombination Repair
por: Ghosh, Ishita, et al.
Publicado: (2023)

Identification of a de novo mutation in TLK1 associated with a neurodevelopmental disorder and immunodeficiency
por: Villamor-Payà, Marina, et al.
Publicado: (2023)

TLK1B promotes repair of UV-damaged DNA through chromatin remodeling by Asf1
por: Sen, Siddhartha P, et al.
Publicado: (2006)

Maintenance of cell fates and regulation of the histone variant H3.3 by TLK kinase in Caenorhabditis elegans
por: Shibata, Yukimasa, et al.
Publicado: (2019)

The interaction between ASF1B and TLK1 promotes the malignant progression of low-grade glioma
por: Zhang, Zifa, et al.
Publicado: (2023)

A dominant negative mutant of TLK1 causes chromosome missegregation and aneuploidy in normal breast epithelial cells
por: Sunavala-Dossabhoy, Gulshan, et al.
Publicado: (2003)

Targeting the TLK1/NEK1 DDR axis with Thioridazine suppresses outgrowth of androgen independent prostate tumors
por: Singh, Vibha, et al.
Publicado: (2019)

Inactive Tlk associating with Tak1 increases p38 MAPK activity to prolong the G2 phase
por: Liaw, Gwo-Jen, et al.
Publicado: (2019)

The TLK1/Nek1 axis contributes to mitochondrial integrity and apoptosis prevention via phosphorylation of VDAC1
por: Singh, Vibha, et al.
Publicado: (2020)

Interaction of TLK1 and AKTIP as a Potential Regulator of AKT Activation in Castration-Resistant Prostate Cancer Progression
por: Khalil, Md Imtiaz, et al.
Publicado: (2021)

Increased plasma levels of circPTP4A2 and circTLK2 are associated with stroke injury
por: Wang, Xingzhi, et al.
Publicado: (2023)

Decay of /sup 199m, g/Po: isomeric transitions in /sup 199/PO and /sup 199/BI
por: Bingham, C R, et al.
Publicado: (1981)

Tousled kinase TLK1B mediates chromatin assembly in conjunction with Asf1 regardless of its kinase activity
por: De Benedetti, Arrigo
Publicado: (2010)

TLK1B mediated phosphorylation of Rad9 regulates its nuclear/cytoplasmic localization and cell cycle checkpoint
por: Awate, Sanket, et al.
Publicado: (2016)

CircTLK1 promotes the proliferation and metastasis of renal cell carcinoma by sponging miR-136-5p
por: Li, Jianfa, et al.
Publicado: (2020)

The Local Anaesthetic Procaine Prodrugs ProcCluster(®) and Procaine Hydrochloride Impair SARS-CoV-2 Replication and Egress In Vitro
por: Häring, Clio, et al.
Publicado: (2023)

De Novo and Inherited Loss-of-Function Variants in TLK2: Clinical and Genotype-Phenotype Evaluation of a Distinct Neurodevelopmental Disorder
por: Reijnders, Margot R.F., et al.
Publicado: (2018)

TLK1‐mediated MK5‐S354 phosphorylation drives prostate cancer cell motility and may signify distinct pathologies
por: Khalil, Md Imtiaz, et al.
Publicado: (2022)

Tetrazine-mediated bioorthogonal prodrug–prodrug activation
por: Neumann, Kevin, et al.
Publicado: (2018)

Prodrugs and prodrug-activated systems in gene therapy
por: Sheikh, Semira, et al.
Publicado: (2021)

Tousled kinase TLK1B counteracts the effect of Asf1 in inhibition of histone H3–H4 tetramer formation
por: De Benedetti, Arrigo
Publicado: (2009)

circTLK1 facilitates the proliferation and metastasis of renal cell carcinoma by regulating miR-495-3p/CBL axis
por: Lei, Xiangli, et al.
Publicado: (2021)

Retraction Note: CircTLK1 promotes the proliferation and metastasis of renal cell carcinoma by sponging miR-136-5p
por: Li, Jianfa, et al.
Publicado: (2023)

Health Tract, No. 199: Studio
Publicado: (1865)

Isolation of specific and biologically active peptides that bind cells from patients with acute myeloid leukemia (AML)
por: Galili, Naomi, et al.
Publicado: (2008)

Translation of the radioresistance kinase TLK1B is induced by γ-irradiation through activation of mTOR and phosphorylation of 4E-BP1
por: Sunavala-Dossabhoy, Gulshan, et al.
Publicado: (2004)

Circular RNA TLK1 Exerts Oncogenic Functions in Hepatocellular Carcinoma by Acting as a ceRNA of miR-138-5p
por: Lu, Yan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1g7dl896abht6nq6p0jurk7051